High-dose-rate brachytherapy for facial skin cancer: Outcome and toxicity assessment for 71 cases.
Fiche publication
Date publication
mars 2021
Journal
Brachytherapy
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier
Tous les auteurs :
Renard S, Salleron J, Py JF, Cuenin M, Buchheit I, Marchesi V, Huger S, Meknaci E, Peiffert D
Lien Pubmed
Résumé
In France, the reference technique for skin cancer was low-dose-rate brachytherapy (BT) delivered via iridium wire. At the end of their commercialization in 2015 we have replaced them by high-dose-rate (HDR) BT via interstitial catheters. We assessed efficacy and tolerance as soon as this technique was implemented.
Mots clés
Brachytherapy, Elderly, HDR, Skin cancer
Référence
Brachytherapy. 2021 Mar 5;: